These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 330868)

  • 1. Delayed foreign-body tumorigenesis in mice infected with lactate dehydrogenase-elevating virus: Brief communication.
    Brinton-Darnell M; Brand I
    J Natl Cancer Inst; 1977 Sep; 59(3):1027-9. PubMed ID: 330868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression studies in foreign body tumorigenesis: no evidence for tumor-specific antigenicity.
    Michelich VJ; Buoen LC; Brand KG
    J Natl Cancer Inst; 1977 Mar; 58(3):257-61. PubMed ID: 320346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gonadectomy on foreign-body tumorigenesis in CBA/H mice.
    Michelich VJ; Brand KG
    J Natl Cancer Inst; 1980 Apr; 64(4):807-8. PubMed ID: 6988625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foreign-body tumors of mice: strain and sex differences in latency and incidence.
    Brand I; Buoen LC; Brand KG
    J Natl Cancer Inst; 1977 May; 58(5):1443-7. PubMed ID: 323507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreign-body tumorigenesis: in vitro isolation and expansion of preneoplastic clonal cell populations.
    Buoen LC; Brand I; Brand KG
    J Natl Cancer Inst; 1975 Sep; 55(3):721-3. PubMed ID: 1099220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of lactate dehydrogenase by SJL/J mice infected with lactate dehydrogenase-elevating virus.
    Brinton MA; Plagemann PG
    J Reticuloendothel Soc; 1983 May; 33(5):391-400. PubMed ID: 6842466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
    Broen JB; Bradley DS; Powell KM; Cafruny WA
    Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foreign-body tumorigenesis by vinyl chloride vinyl acetate copolymer: no evidence for chemical cocarcinogenesis.
    Brand KG; Buoen LC; Brand I
    J Natl Cancer Inst; 1975 May; 54(5):1259-62. PubMed ID: 1127739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
    Gómez KA; Coutelier JP; Retegui LA
    Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and immunology of lactic dehydrogenase virus (LDV)].
    Inada T; Yamazaki S
    Uirusu; 1987 Dec; 37(2):193-210. PubMed ID: 3328922
    [No Abstract]   [Full Text] [Related]  

  • 14. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immunoglobulin isotype blood levels, splenic B-cell phenotypes, and spleen cell immunoglobulin gene expression in mice infected with lactate dehydrogenase-elevating virus.
    Hovinen DE; Bradley DS; Cafruny WA
    Viral Immunol; 1990; 3(1):27-40. PubMed ID: 1967527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review.
    Brand KG; Buoen LC; Johnson KH; Brand I
    Cancer Res; 1975 Feb; 35(2):279-86. PubMed ID: 1089044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to cryptic epitopes elicited by infection with lactate dehydrogenase-elevating virus.
    Gómez KA; Coutelier J; Mathieu PA; Lustig L; Retegui LA
    Scand J Immunol; 2000 May; 51(5):447-53. PubMed ID: 10792835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression.
    Hayashi T; Mori I; Yamamoto H
    Int J Exp Pathol; 1992 Oct; 73(5):593-601. PubMed ID: 1419777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
    McDonald TL; Donnelly T; Weber A; Quenette L
    Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.